Statistics

Total Visits

Views
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial 816

Total Visits per Month

November 2024 December 2024 January 2025 February 2025 March 2025 April 2025 May 2025
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial 28 27 23 29 33 22 9

File Downloads

Views
Kyriazopoulou.pdf 296

Top Country Views

Views

Top City Views

Views